Cargando…

HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study

SIMPLE SUMMARY: This study aimed at assessing HPV16 and HPV18 viral loads to predict the development of cervical high-grade lesion. Among 885 women positive for hrHPV and presenting no or mild cytological abnormalities, HPV16 and HPV18 prevalence was 25.9% and 8.4%, respectively. Of those women, 135...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baumann, Antoine, Henriques, Julie, Selmani, Zohair, Meurisse, Aurélia, Lepiller, Quentin, Vernerey, Dewi, Valmary-Degano, Séverine, Paget-Bailly, Sophie, Riethmuller, Didier, Ramanah, Rajeev, Mougin, Christiane, Prétet, Jean-Luc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394477/ https://www.ncbi.nlm.nih.gov/pubmed/34439304 http://dx.doi.org/10.3390/cancers13164149

Ejemplares similares

New HPV16 viral biomarkers to understand the progression of cervical lesions towards cancer
por: Prétet, Jean-Luc, et al.
Publicado: (2014)

Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial
por: Debernardi, Alice, et al.
Publicado: (2022)

The exon junction complex core factor eIF4A3 is a key regulator of HPV16 gene expression
por: Meznad, Koceila, et al.
Publicado: (2021)

Comparative RNA sequencing reveals that HPV16 E6 abrogates the effect of E6*I on ROS metabolism
por: Paget-Bailly, Philippe, et al.
Publicado: (2019)

Exosomes and Other Extracellular Vesicles in HPV Transmission and Carcinogenesis
por: Guenat, David, et al.
Publicado: (2017)

Development and interlaboratory agreement of real-time PCR for HPV16 quantification in liquid-based cervical samples
por: Guenat, David, et al.
Publicado: (2018)

Validation of Novaprep(®) HQ+ liquid-based cytology medium for high-risk human papillomavirus detection by hc2
por: Guenat, David, et al.
Publicado: (2016)

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
por: Riethmuller, Didier, et al.
Publicado: (2015)

Prevention and control of HPV and HPV-related cancers in France: the evolving landscape and the way forward – a meeting report
por: Waheed, Dur-e-Nayab, et al.
Publicado: (2023)

Apoptotic HPV Positive Cancer Cells Exhibit Transforming Properties
por: Gaiffe, Emilie, et al.
Publicado: (2012)

Effect of Infliximab on the UVB-Induced Apoptosis of Keratinocytes Infected by HPV38 E6/E7
por: Aubin, François, et al.
Publicado: (2013)

Anti-Telomerase CD4(+) Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials
por: Spehner, Laurie, et al.
Publicado: (2020)

High risk HPV genotypes in Belarus
por: Eremin, VF, et al.
Publicado: (2014)

Anal High-risk HPV and Liquid-based Cytology of Immunocompetent Brazilian Women with Genital High-risk HPV
por: Melo, Karla Maria Rêgo Leopoldo, et al.
Publicado: (2022)

Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15–23 years
por: Baudu, Ariane, et al.
Publicado: (2014)

Rapid detection of high-risk HPV16 and HPV18 based on microchip electrophoresis
por: Fan, Zhaoxuan, et al.
Publicado: (2020)

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening
por: Aitken, Clare A, et al.
Publicado: (2019)

Quality control for normal liquid-based cytology: Rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection?
por: Depuydt, Christophe E, et al.
Publicado: (2009)

5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression
por: Morel, Adrien, et al.
Publicado: (2017)

Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol
por: Mouillet, Guillaume, et al.
Publicado: (2019)

Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma
por: Kim, Stefano, et al.
Publicado: (2020)

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples
por: Bell, Margo, et al.
Publicado: (2023)

Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
por: Sung, Yeoun Eun, et al.
Publicado: (2016)

Therapeutic vaccines for high-risk HPV-associated diseases
por: Chabeda, Aleyo, et al.
Publicado: (2017)

Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid
por: Rabaan, Ali A., et al.
Publicado: (2018)

HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions
por: Ilisiu, Minodora Bianca, et al.
Publicado: (2019)

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
por: Wei, Baojun, et al.
Publicado: (2020)

Detection of high-risk HPV in FFPE specimens of various tumours using the BD Onclarity™ HPV Assay
por: van der Geize, Robert, et al.
Publicado: (2022)

Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection
por: Li, Chenxi, et al.
Publicado: (2023)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

The Distribution and Prevalence of High-Risk HPV Genotypes Other than HPV-16 and HPV-18 among Women Attending Gynecologists’ Offices in Kazakhstan
por: Aimagambetova, Gulzhanat, et al.
Publicado: (2021)

Comparison of the Digene HPV Genotyping LQ Test and the PANArray HPV Genotyping Chip for Detection of High-Risk or Probable High-Risk Human Papillomavirus Genotypes
por: Park, Kyung Sun, et al.
Publicado: (2014)

Prenatal Diagnosis of a Segmental Small Bowel Volvulus with Threatened Premature Labor
por: Monard, Barbara, et al.
Publicado: (2017)

Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities
por: Johansson, Hanna, et al.
Publicado: (2015)

Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence
por: Namujju, Proscovia B, et al.
Publicado: (2011)

Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study
por: Gaiffe, Emilie, et al.
Publicado: (2022)

HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer
por: Cabel, L., et al.
Publicado: (2021)

HPV genotyping and risk factors for anal high-risk HPV infection in men who have sex with men from Toronto, Canada
por: Choi, Yoojin, et al.
Publicado: (2021)

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
por: Paz-Zulueta, María, et al.
Publicado: (2018)

The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
por: So, Kyeong A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f62786rdnnr5o233o7q1ji8v5p